Jump Financial, LLC Rapt Therapeutics, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$6.87 - $26.45 $353,805 - $1.36 Million	51,500 New	51,500 $462,000
Q1 2023 Oct 21, 2024	BUY	$17.19 - $30.8 $579,474 - $1.04 Million	33,710 New	33,710 $618,000
Q1 2023 May 03, 2023	BUY	$17.19 - $30.8 $579,474 - $1.04 Million	33,710 New	33,710 $618,000
Q4 2021 Feb 10, 2022	SELL	$29.5 - $39.5 $822,430 - $1.1 Million	-27,879 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$29.86 - $39.47 $832,466 - $1.1 Million	27,879 New	27,879 $866,000
Q1 2021 May 17, 2021	SELL	$16.0 - $24.46 $207,360 - $317,001	-12,960 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.89 - $40.87 $205,934 - $529,675	12,960 New	12,960 $256,000

105

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $35.6M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.